China's Exports Of Pharmaceutical Preparations Speed Up The Upgrading Of The Pace Of U.s. And

Editor's Note China has the world's pharmaceutical producing countries

, API And intermediate production and export largest in the world, but not the export of agents has been a major breakthrough?? In addition to low-end markets such as Southeast Asia and Africa, a slight gains, the global pharmaceutical consumption in the occupied Nearly nine European and American markets was virtually nonexistent. China's production Drugs To the world, developing Europe and the United States market with its importance. High-tech barriers facing U.S. and European markets, high market risk and strict and unfamiliar legal norms, how firm to go out and overcome the obstacles, many enterprises in China urgent problem.

Author of Chinese medicine preparations exported to Europe market opportunities and challenges facing analyzed, and the corresponding countermeasures and suggestions. Author points out: China Pharmaceutical companies Should seize the global pharmaceutical manufacturing centers to Asia's opportunities, to overcome its own lack of active participation in international production of pharmaceutical preparations, to achieve industrial upgrading. Change its view with the current state of economic development pattern of the industry is worth serious consideration.

Into the European market, is the current expectations of many domestic pharmaceutical companies, in this context, opportunities and challenges, which requires the industry recognize their own shortcomings and domestic and international environment, enhance the software and hardware development.

Good opportunities facing 1. Generic Expansion of markets to provide opportunities for the export of agents

Recent years, the international pharmaceutical industry will usher in the medical history of a rare concentration of drug patents expire favorable period. Statistics show that in 2008, the global deep-rooted Sell About 200 billion dollars the amount of drug patents expire, the 2011 to 2015, the scale of a further rise to 770 million. With the "blockbuster" drugs in the world-class patent exclusivity period ends, the amount of global sales of generic drugs to 10% expected growth rate of 15%, well above the global pharmaceutical market growth rate.

The development of generic drugs also have been encouraged by U.S. and European governments. In recent years, forced by population aging intensifies, health care spending surge, European and American developed countries vigorously promote generic drug substitution of the original research plan, hoping to get low-cost global sourcing of pharmaceutical products, which also contributed to the generics market growth. The country's bulk drugs, intermediates, packaging, equipment and labor is relatively cheap, cost advantage the export of agents, a number of patented drugs in the world, exclusive of the end has been established for the generic pharmaceutical industry in China based on it can be said is a great opportunity.

2. National policies to support enterprises motivated

China currently has more than 4700 to the GMP requirements pharmaceutical companies, many domestic enterprises in international practice cGMP transform a certain foundation. Meanwhile, in the past few decades, China's pharmaceutical companies have formed a complete set with imitation-based research and development system, production equipment, personnel and technological level has been greatly improved, my copy in generic terms already has a strong international competitiveness. There is some obstacle

And Chinese medicine formulations of traditional export markets of different European and American countries through the improvement of intellectual property protection, and full and strict access conditions and fierce market competition, and build a high market barriers. This pharmaceutical preparations to enter the European market in China caused some difficulties, mainly in the following areas:

1. Europe and the United States market, the full protection of intellectual property

For the preparation of production, intellectual property protection of pharmaceuticals developed countries in Europe and the United States consists of three parts: the raw material drug production process patent protection, patent protection of drug production and clinical application of patent protection. In the usual sense of the original drug's patent expired research refers to the clinical application of exclusive patent protection expires, generic drugs have the same ingredients are listed on the eligibility of sale. However, the preparation of the production process is usually longer than the clinical application of patent protection, and thus exports when imitation agents still need to avoid infringing the production of drug substances and drug patents. This is what we often referred to as "avoid the patent process." The so-called "Avoid the patent process" is in the drug production process, to avoid the drug originally developed within the company in its patent covering the production process, using patented technology to produce innovative than the same final product. This is of pharmaceutical R & D and technological strength have higher requirements, a slight negligence, the original research and pharmaceutical companies will face infringement proceedings, the law is very risky.

China's Exports Of Pharmaceutical Preparations Speed Up The Upgrading Of The Pace Of U.s. And

By: zzj89@foxmail.com

POST COMMENT

"wireless City" Behind The Scene: China Three Independent Combat Foreign Brands China Sheep To Build A Base In China, Fuyang White Board Attract A Large Number Of Foreign Perspective, China's Valve Industry Positive Outlook Up To Date Telecommunications Directory Of China Development Trend Of China's Machine Tool Manufacturing Industry Stamping Die Industry In China's Export Surge In The Latest Top 8 Inch Wholesale Tablet Pcs From Epathchina Us-china Stand-off Could Get Ugly. Measuring The Rapid Development Of China's Industry To Become The World's Second China Wind Power Converter Industry Situation And Prospects "china's Leather Capital" For Strong Storms Building Empire Through Argumentation: Debating Salt And Iron In Western Han China